guanfacine has been researched along with Migraine Disorders in 1 studies
Guanfacine: A centrally acting antihypertensive agent with specificity towards ADRENERGIC ALPHA-2 RECEPTORS.
Migraine Disorders: A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tfelt-Hansen, P | 1 |
1 other study available for guanfacine and Migraine Disorders
| Article | Year |
|---|---|
Why is guanfacine recommended by AHS and ANN for migraine prevention?
Topics: Adrenergic alpha-2 Receptor Agonists; Guanfacine; Humans; Migraine Disorders; Practice Guidelines as | 2014 |